Title |
The Effect of Monthly Sulfadoxine-Pyrimethamine, Alone or with Azithromycin, on PCR-Diagnosed Malaria at Delivery: A Randomized Controlled Trial
|
---|---|
Published in |
PLOS ONE, July 2012
|
DOI | 10.1371/journal.pone.0041123 |
Pubmed ID | |
Authors |
Mari Luntamo, Anne-Maria Rantala, Steven R. Meshnick, Yin Bun Cheung, Teija Kulmala, Kenneth Maleta, Per Ashorn |
Abstract |
New regimens for intermittent preventive treatment in pregnancy (IPTp) against malaria are needed as the effectiveness of the standard two-dose sulfadoxine-pyrimethamine (SP) regimen is under threat. Previous trials have shown that IPTp with monthly SP benefits HIV-positive primi- and secundigravidae, but there is no conclusive evidence of the possible benefits of this regimen to HIV-negative women, or to a population comprising of both HIV-positive and -negative women of different gravidities. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 2% |
Burkina Faso | 1 | <1% |
Indonesia | 1 | <1% |
Unknown | 100 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 21 | 20% |
Student > Master | 21 | 20% |
Student > Ph. D. Student | 16 | 15% |
Student > Bachelor | 7 | 7% |
Other | 6 | 6% |
Other | 13 | 13% |
Unknown | 20 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 34 | 33% |
Agricultural and Biological Sciences | 16 | 15% |
Nursing and Health Professions | 10 | 10% |
Biochemistry, Genetics and Molecular Biology | 4 | 4% |
Immunology and Microbiology | 4 | 4% |
Other | 11 | 11% |
Unknown | 25 | 24% |